Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Background: Acquired immunity to Plasmodium falciparum malaria is mainly mediated by immunoglobulin G (IgG) targeting erythrocyte membrane protein 1 (PfEMP1). These adhesins mediate infected erythrocyte (IE) sequestration, protecting IEs from splenic destruction. PfEMP1-specific IgG is therefore thought to protect mainly by inhibiting IE sequestration. VAR2CSA-type PfEMP1 mediates placental IE sequestration, putting pregnant women exposed to P falciparum parasites at risk of placental malaria (PM). Methods: Levels and Fc-afucosylation of VAR2CSA-specific plasma IgG were measured by a modified enzyme-linked immunosorbent assay (FEASI). We also measured the ability of the IgG to inhibit IE adhesion and to induce natural killer (NK) cell degranulation. The results were related to parity and clinical pregnancy outcomes. Results: Parity was positively correlated with levels and Fc-afucosylation of VAR2CSA-specific IgG, and with birth weight and plasma IgG inhibition of IE adhesion in vitro. Fc-afucosylation of VAR2CSA-specific IgG increased NK–cell degranulation. Women with Fc-afucosylated VAR2CSA–specific IgG had a reduced risk of delivering a low birth weight (LBW) baby, but not of PM or anemia. Conclusions: Fc-afucosylated VAR2CSA-specific IgG effectively induced NK–cell degranulation and was associated with protection against LBW, independent of IgG levels. Our study has implications for the development of VAR2CSA-based subunit vaccines, which exclusively induce Fc-fucosylated IgG.
Funding Information
  • DANIDA (12-081RH, 17-02-KU)
  • Independent Research Fund Denmark (0134-00123B)
  • Landsteiner Foundation for Blood Transfusion Research (1721)
  • European Union Seventh Framework Program (FP7-HEALTH-2012-INNOVATION, 200889)

This publication has 47 references indexed in Scilit: